Cargando…

Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report

INTRODUCTION: Sinus bradycardia has been reported after administration of pulse dose steroids, although most cases have occurred in children and are asymptomatic. We report a case of acute symptomatic sinus bradycardia due to pulse dose steroids in a woman with multiple sclerosis. Interestingly, thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundu, Amartya, Fitzgibbons, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581459/
https://www.ncbi.nlm.nih.gov/pubmed/26400725
http://dx.doi.org/10.1186/s13256-015-0701-x
_version_ 1782391567727722496
author Kundu, Amartya
Fitzgibbons, Timothy P.
author_facet Kundu, Amartya
Fitzgibbons, Timothy P.
author_sort Kundu, Amartya
collection PubMed
description INTRODUCTION: Sinus bradycardia has been reported after administration of pulse dose steroids, although most cases have occurred in children and are asymptomatic. We report a case of acute symptomatic sinus bradycardia due to pulse dose steroids in a woman with multiple sclerosis. Interestingly, this patient also suffered from inappropriate sinus tachycardia due to autonomic involvement of multiple sclerosis. CASE PRESENTATION: A 48-year-old Caucasian woman with multiple sclerosis and chronic palpitations due to inappropriate sinus tachycardia was prescribed a 5-day course of intravenous methylprednisolone for treatment of an acute flare. Immediately following the fourth dose of intravenous methylprednisolone, she developed dyspnea, chest heaviness, and lightheadedness. She was referred to the emergency department where an electrocardiogram showed marked sinus bradycardia (40 beats per minute). Initial laboratory test results, including a complete blood count, basic metabolic profile and cardiac biomarkers, were normal. She was admitted for observation on telemetry monitoring. Her heart rate gradually increased and her symptoms resolved. Her outpatient dose of atenolol, taken for symptomatic inappropriate sinus tachycardia, was resumed. CONCLUSIONS: Our patient’s acute symptoms were attributed to symptomatic sinus bradycardia due to pulse dose steroid treatment. Although several theories have been suggested to explain this phenomenon, the exact mechanism still remains unknown. It does not warrant any specific treatment, as it is a self-limiting side effect that resolves after discontinuing steroid infusion. Young patients who are free of any active cardiac conditions can safely be administered pulse dose steroids without monitoring. However, older patients with active cardiac conditions should have heart rate and blood pressure monitoring during infusion. Our patient also suffered from inappropriate sinus tachycardia, a manifestation of autonomic involvement of multiple sclerosis that has not been previously described. This case has implications for the pathogenesis and treatment of dysautonomia in patients with multiple sclerosis.
format Online
Article
Text
id pubmed-4581459
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45814592015-09-25 Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report Kundu, Amartya Fitzgibbons, Timothy P. J Med Case Rep Case Report INTRODUCTION: Sinus bradycardia has been reported after administration of pulse dose steroids, although most cases have occurred in children and are asymptomatic. We report a case of acute symptomatic sinus bradycardia due to pulse dose steroids in a woman with multiple sclerosis. Interestingly, this patient also suffered from inappropriate sinus tachycardia due to autonomic involvement of multiple sclerosis. CASE PRESENTATION: A 48-year-old Caucasian woman with multiple sclerosis and chronic palpitations due to inappropriate sinus tachycardia was prescribed a 5-day course of intravenous methylprednisolone for treatment of an acute flare. Immediately following the fourth dose of intravenous methylprednisolone, she developed dyspnea, chest heaviness, and lightheadedness. She was referred to the emergency department where an electrocardiogram showed marked sinus bradycardia (40 beats per minute). Initial laboratory test results, including a complete blood count, basic metabolic profile and cardiac biomarkers, were normal. She was admitted for observation on telemetry monitoring. Her heart rate gradually increased and her symptoms resolved. Her outpatient dose of atenolol, taken for symptomatic inappropriate sinus tachycardia, was resumed. CONCLUSIONS: Our patient’s acute symptoms were attributed to symptomatic sinus bradycardia due to pulse dose steroid treatment. Although several theories have been suggested to explain this phenomenon, the exact mechanism still remains unknown. It does not warrant any specific treatment, as it is a self-limiting side effect that resolves after discontinuing steroid infusion. Young patients who are free of any active cardiac conditions can safely be administered pulse dose steroids without monitoring. However, older patients with active cardiac conditions should have heart rate and blood pressure monitoring during infusion. Our patient also suffered from inappropriate sinus tachycardia, a manifestation of autonomic involvement of multiple sclerosis that has not been previously described. This case has implications for the pathogenesis and treatment of dysautonomia in patients with multiple sclerosis. BioMed Central 2015-09-24 /pmc/articles/PMC4581459/ /pubmed/26400725 http://dx.doi.org/10.1186/s13256-015-0701-x Text en © Kundu and Fitzgibbons. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Kundu, Amartya
Fitzgibbons, Timothy P.
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
title Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
title_full Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
title_fullStr Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
title_full_unstemmed Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
title_short Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
title_sort acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581459/
https://www.ncbi.nlm.nih.gov/pubmed/26400725
http://dx.doi.org/10.1186/s13256-015-0701-x
work_keys_str_mv AT kunduamartya acutesymptomaticsinusbradycardiainawomantreatedwithpulsedosesteroidsformultiplesclerosisacasereport
AT fitzgibbonstimothyp acutesymptomaticsinusbradycardiainawomantreatedwithpulsedosesteroidsformultiplesclerosisacasereport